Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Response Biomed Corp RPBIF

"Response Biomedical Corp is engaged in the research, development, commercialization and distribution of diagnostic technologies for the medical central-lab testing, point of care (POC) testing and on-site environmental testing markets."


GREY:RPBIF - Post by User

Bullboard Posts
Post by Hurting20on Jan 12, 2005 11:14pm
157 Views
Post# 8423573

sleazy girl you got it wrong

sleazy girl you got it wrongI didn't say they invented their hybrid sales plan, just that this was not there plan. A resort after the failure of trying to get a cardiac marketing partner....which makes the most sense. I am not the only one who thinks this doesnt' make sense. Not going to .50. how do you know? You guys have had 3 years to make it to a buck! If you don't think rbm is overvalued explain this. They get approval for the chinese market, which should add value but it doesn't. The stock goes nowhere. Way too much slack in the system. What do you think will happen if for the next 8 quarters sales run at around 1.2 million? A share consolidation. 100 million outstanding shares. Why is this not possible as there is no sales momentum in fact the data shows slowing quarterly sales.
Bullboard Posts